You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 13, 2025

Drug Price Trends for NAPROXEN


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for NAPROXEN

Average Pharmacy Cost for NAPROXEN

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug NameNDCPrice/Unit ($)UnitDate
NAPROXEN 125 MG/5 ML SUSPEN 69238-1730-02 0.32800 ML 2025-03-19
NAPROXEN 125 MG/5 ML SUSPEN 70954-0151-10 0.45922 ML 2025-03-19
NAPROXEN 125 MG/5 ML SUSPEN 42192-0619-16 0.32800 ML 2025-03-19
NAPROXEN 250 MG TABLET 49483-0619-01 0.05176 EACH 2025-03-19
NAPROXEN 125 MG/5 ML SUSPEN 00054-3630-63 0.45922 ML 2025-03-19
NAPROXEN-ESOMEPRAZ DR 500-20 MG 70748-0216-07 4.65410 EACH 2025-03-19
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 6 of 6 entries

Best Wholesale Price for NAPROXEN

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)UnitDatesPrice Type
NAPRELAN ORAL EXTENDED RELEASE 375MG TAB TWi Pharmaceuticals USA, Inc. 52427-0272-01 100 1467.82 14.67820 EACH 2023-11-01 - 2028-01-31 FSS
NAPRELAN ORAL EXTENDED RELEASE 750MGTAB TWi Pharmaceuticals USA, Inc. 52427-0274-30 30 501.46 16.71533 EACH 2024-01-01 - 2028-01-31 FSS
NAPROXEN 125MG/5ML SUSP,ORAL Golden State Medical Supply, Inc. 00054-3630-63 500ML 492.41 0.98482 ML 2023-06-23 - 2028-06-14 FSS
NAPROXEN 125MG/5ML SUSP,ORAL Golden State Medical Supply, Inc. 00054-3630-63 500ML 462.36 0.92472 ML 2023-06-15 - 2028-06-14 FSS
NAPROXEN NA 750MG TAB,SA TWi Pharmaceuticals USA, Inc. 47781-0155-30 30 302.53 10.08433 EACH 2024-01-01 - 2028-01-31 FSS
NAPROXEN 500MG TAB AvKare, LLC 42291-0628-18 180 14.40 0.08000 EACH 2023-09-22 - 2028-06-14 FSS
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Unit>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 1 to 6 of 6 entries

Market Analysis and Price Projections for Naproxen

Overview of the Naproxen Market

Naproxen, a widely used nonsteroidal anti-inflammatory drug (NSAID), is experiencing significant market dynamics driven by various factors. Here’s a comprehensive analysis of the current market situation and future projections.

Global Market Size and Growth

The global naproxen market has been growing steadily. In 2019, the market size was valued at millions of US dollars and is projected to reach a higher value by 2025, with a compound annual growth rate (CAGR) over the forecast period[1][3].

Key Drivers of Market Growth

Increasing Prevalence of Inflammatory Conditions

The rising prevalence of inflammatory conditions such as arthritis and other musculoskeletal disorders is a primary driver of the naproxen market. These conditions necessitate the use of effective analgesics and anti-inflammatory medications, thereby increasing the demand for naproxen[2].

Pharmaceutical Sector Demand

Robust demand from the pharmaceutical sector, particularly in regions like North America and Europe, is another significant factor. This demand is driven by the need for naproxen in the production of various medications[4].

Regional Market Analysis

North America

In North America, the naproxen sodium market has experienced a steady upward trajectory in prices. Key drivers include supply constraints, elevated production costs, and geopolitical factors. Supply chain disruptions, natural disasters, and currency fluctuations have also contributed to price increases. The U.S. market, in particular, has been affected by supply chain disruptions originating from the Asia-Pacific region, leading to higher production costs and tighter margins for distributors[4].

Europe

The European naproxen market, led by Germany, has displayed robust pricing trends. Seasonal demand, especially during colder months, and economic factors such as currency fluctuations and logistics challenges have influenced market conditions. Supply disruptions, including planned plant maintenance, have further constrained market availability and supported price increases[4].

Asia-Pacific

In the Asia-Pacific region, particularly in China, the naproxen sodium market has seen significant price fluctuations. Strong demand from both domestic and international markets has driven prices higher. However, in the first quarter of 2024, the market experienced a decline due to subdued demand from downstream industries, surplus inventories, and reduced production expenses[2][4].

Price Trends and Projections

Recent Price Movements

In the second quarter of 2024, naproxen sodium prices in China reached 36,121 USD/MT, while in Germany, prices were at 37,489 USD/MT. In the U.S., prices were around 35,550 USD/MT in March 2024[2][4].

Anticipated Rebound

Despite recent declines, industry experts anticipate a modest rebound in naproxen prices, particularly in the U.S. market, starting from April 2024. This rebound is expected to be driven by renewed demand from pharmaceutical companies and stabilization in raw material costs[5].

Impact of Seasonal and Environmental Factors

Higher temperatures can affect the handling and processing of naproxen API, leading to degradation and potential safety and efficacy issues. This has prompted merchants to reduce inventories to prevent product expiration, which is expected to influence price dynamics in the forthcoming period[5].

Supply Chain and Production Costs

Raw Material Costs

Escalating raw material costs, particularly for acetic anhydride, have significantly impacted the production costs of naproxen. Increased energy prices have also contributed to the rising cost dynamics[2].

Supply Chain Disruptions

Supply chain disruptions, including geopolitical tensions, planned plant maintenance, and logistical challenges such as the Panama Canal drought, have constrained market availability and driven price increases[4].

Market Volatility and Future Outlook

The naproxen sodium market is poised for continued volatility due to global supply chain uncertainties, geopolitical shifts, and economic factors. Analysts predict that the price trend for naproxen sodium will oscillate in the coming quarters, influenced by market demands and global economic conditions[4].

Key Players and Market Competition

The market is dominated by key players such as Teva and Kirsch Pharma GmbH. These companies are focusing on development plans, SWOT analysis, and market competition strategies to maintain their market share and growth prospects[1].

Conclusion

The naproxen market is dynamic and influenced by a variety of factors including demand from the pharmaceutical sector, supply chain disruptions, and raw material costs. While recent price declines have been observed, a modest rebound is anticipated in the coming months driven by renewed demand and stabilization in raw material costs.

Key Takeaways

  • Global Market Growth: The global naproxen market is expected to grow at a significant CAGR from 2019 to 2025.
  • Regional Dynamics: North America, Europe, and the Asia-Pacific region are key markets with varying price trends influenced by local demand and supply factors.
  • Price Projections: A modest rebound in prices is anticipated starting from April 2024, driven by renewed demand and stabilization in raw material costs.
  • Supply Chain Impact: Supply chain disruptions and raw material costs are critical factors influencing market prices.
  • Market Volatility: The market is expected to remain volatile due to global supply chain uncertainties and economic factors.

FAQs

Q: What are the primary drivers of the naproxen market?

A: The primary drivers include the increasing prevalence of inflammatory conditions and robust demand from the pharmaceutical sector.

Q: How have recent price trends been in the naproxen market?

A: Recent price trends have shown declines in some regions due to subdued demand and supply chain disruptions, but a rebound is anticipated starting from April 2024.

Q: Which regions are most affected by supply chain disruptions?

A: North America, particularly the U.S., and Europe have been significantly affected by supply chain disruptions originating from the Asia-Pacific region.

Q: How do seasonal factors impact the naproxen market?

A: Higher temperatures can affect the handling and processing of naproxen API, leading to degradation and potential safety and efficacy issues, prompting inventory reductions.

Q: Who are the key players in the naproxen market?

A: Key players include Teva and Kirsch Pharma GmbH, among others, who are focusing on development plans and market competition strategies.

Sources

  1. Global Naproxen Market to Witness a Pronounce Growth During 2025 - OpenPR
  2. Naproxen Sodium Prices, Chart, News, Demand and Forecast - OpenPR
  3. Naproxen Market Report 2024 (Global Edition) - Cognitive Market Research
  4. Naproxen Sodium Price Trend and Forecast - Procurement Resource
  5. Navigating Naproxen Prices: Anticipating a Q2 Upswing in the US Market - ChemAnalyst

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.